{"id":194537,"name":"TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS)","slug":"tiber-creek-group-on-behalf-of-vertex-pharmaceuticals","state":"DC","country":"United States of America","description":"Government relations.","totalSpending":1680000,"filings":32,"yearlySpending":[{"year":2018,"income":80000},{"year":2019,"income":80000},{"year":2020,"income":80000},{"year":2021,"income":200000},{"year":2022,"income":320000},{"year":2023,"income":320000},{"year":2024,"income":320000},{"year":2025,"income":280000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"HCR","display":"Health Issues"}],"firms":["TIBER CREEK HEALTH STRATEGIES, INC."],"lobbyists":["JAMES HALL"],"govEntities":["SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to rare diseases (cystic fibrosis); Issues related to pharmaceutical pricing","Issues related to rare diseases (cystic fibrosis.","Issues related to rare diseases (cystic fibrosis); Issues related to pharmaceutical pricing","Issues related to rare diseases (cystic fibrosis)","Issues related to rare diseases (cystic fibrosis)"]}